There are 12 resources available
Welcome and learning objectives introduction
Presenter: "Ken Herrmann, DE and A. G. Omlin, CH"
Session: Welcome and introduction
Resources:
Slides
Physics background including diagnostic and therapeutic radionuclides including videos
Presenter: "M. Lassmann, DE"
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
Landscape of systemic therapies for thyroid malignancies
Presenter: "J. A. Krajewska, PL"
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
History of theranostics including radioiodine-therapy
Presenter: "L. Giovanella, CH"
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
Regulatory challenges of developing radiopharmaceuticals
Presenter: "M. Nader, DE"
Session: Session 2 - How to run a theranostic unit and beyond
Resources:
Slides
Webcast
Setting up a theranostic unit (regulatory, radiation safety and reimbursement challenges)
Presenter: "L. Graven, NL"
Session: Session 2 - How to run a theranostic unit and beyond
Resources:
Slides
Webcast
Outlook Towards New Theranostic Concepts (Combination Treatments, Alpha-emitters, antibodies)
Presenter: "K. Lückerath, DE"
Session: Session 2 - How to run a theranostic unit and beyond
Resources:
Slides
Webcast
Landscape of systemic therapies for NETs
Presenter: "D. Ferone, IT"
Session: Session 3 - NETs as role model for theranostics
Resources:
Slides
Webcast
Biology in advanced prostate cancer with a special focus on PSMA across the disease spectrum (primary tumour, upregulation with AR targeted therapies, heterogeneity etc)
Presenter: "N. Rupp, CH"
Session: Session 4 - Expanding Theranostics to prostate cancer
Resources:
Slides
Webcast
Treatment landscape in advanced prostate cancer
Presenter: "A. G. Omlin, CH"
Session: Session 4 - Expanding Theranostics to prostate cancer
Resources:
Slides
Webcast